Alyeska Investment Group’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-202,148
| Closed | -$1.25M | – | 585 |
|
|
2024
Q2 | $1.25M | Hold |
202,148
| – | – | 0.01% | 427 |
|
|
2024
Q1 | $1.91M | Hold |
202,148
| – | – | 0.01% | 366 |
|
|
2023
Q4 | $1.36M | Hold |
202,148
| – | – | 0.01% | 364 |
|
|
2023
Q3 | $898K | Hold |
202,148
| – | – | 0.01% | 408 |
|
|
2023
Q2 | $667K | Buy |
202,148
+50,000
| +33% | +$165K | 0.01% | 442 |
|
|
2023
Q1 | $434K | Buy |
+152,148
| New | +$434K | ﹤0.01% | 395 |
|
|
2021
Q1 | – | Sell |
-452,797
| Closed | -$5.3M | – | 753 |
|
|
2020
Q4 | $5.3M | Buy |
452,797
+244,040
| +117% | +$2.86M | 0.07% | 255 |
|
|
2020
Q3 | $1.66M | Buy |
+208,757
| New | +$1.66M | 0.03% | 366 |
|
|
2020
Q1 | – | Sell |
-75,551
| Closed | -$1.26M | – | 377 |
|
|
2019
Q4 | $1.26M | Sell |
75,551
-74,714
| -50% | -$1.24M | 0.02% | 297 |
|
|
2019
Q3 | $998K | Buy |
+150,265
| New | +$998K | 0.01% | 296 |
|